Stimcell Energetics (STME) Operating Income Growth (1y) (2017 - 2024)
Stimcell Energetics (STME) Operating Income Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.18% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -80.57% |
| Feb 29, 2024 | 45.41% |
| Nov 30, 2023 | 67.77% |
| Aug 31, 2023 | 64.79% |
| May 31, 2023 | 57.97% |
| Feb 28, 2023 | 6.04% |
| Nov 30, 2022 | 22.57% |
| Aug 31, 2022 | 38.14% |
| May 31, 2022 | 13.89% |
| Feb 28, 2022 | 33.73% |
| Nov 30, 2021 | 6.02% |
| Aug 31, 2021 | -20.36% |
| May 31, 2021 | 27.27% |
| Feb 28, 2021 | 33.14% |
| Nov 30, 2020 | 39.45% |
| Aug 31, 2020 | 18.28% |
| May 31, 2020 | 79.55% |
| Feb 29, 2020 | -252.18% |
| Nov 30, 2019 | -340.02% |
| Aug 31, 2019 | -198.92% |